Gene · 4922
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood Transfusion Components Inducing Severe Allergic Reactions: The First Case of Kounis Syndrome Induced by Platelet Transfusion. | Vaccines (Basel) | 2023 | 36851100 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2. | ACS Omega | 2023 | 36844603 | PubTator, text mining | PubMed |
| Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies. | Int J Mol Sci | 2023 | 36835022 | PubTator, text mining | PubMed |
| Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story. | Int J Mol Sci | 2023 | 36834796 | PubTator, text mining | PubMed |
| An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. | Biomedicines | 2023 | 36831120 | PubTator, text mining | PubMed |
| CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors. | Biomedicines | 2023 | 36831112 | PubTator, text mining | PubMed |
| Investigating the competition between ACE2 natural molecular interactors and SARS-CoV-2 candidate inhibitors. | Chem Biol Interact | 2023 | 36822303 | PubTator, text mining | PubMed |
| Clinical advancement of precision theranostics in prostate cancer. | Front Oncol | 2023 | 36816956 | PubTator, text mining | PubMed |
| Advances in photobiomodulation for cognitive improvement by near-infrared derived multiple strategies. | J Transl Med | 2023 | 36814278 | PubTator, text mining | PubMed |
| Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry. | Nucl Med Biol | 2023 | 36805869 | PubTator, text mining | PubMed |
| X-ray crystallographic and mutational analysis of the NylC precursor: catalytic mechanism of autocleavage and substrate hydrolysis of nylon hydrolase. | FEBS J | 2023 | 36799721 | PubTator, text mining | PubMed |
| Catalytic site mutations confer multiple states of G protein activation. | Sci Signal | 2023 | 36787384 | PubTator, text mining | PubMed |
| Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions. | JACC Basic Transl Sci | 2023 | 36777165 | PubTator, text mining | PubMed |
| Increased adipose tissue lymphatic vessel density inhibits thermogenesis through elevated neurotensin levels. | Front Cell Dev Biol | 2023 | 36776563 | PubTator, text mining | PubMed |
| Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer. | Nat Commun | 2023 | 36765047 | PubTator, text mining | PubMed |
| Understanding Neuropeptide Transmission in the Brain by Optical Uncaging and Release. | ACS Chem Neurosci | 2023 | 36719384 | PubTator, text mining | PubMed |
| Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1). | Cell Rep | 2023 | 36680775 | PubTator, text mining | PubMed |
| Emerging Antimicrobial and Immunomodulatory Fiber-Based Scaffolding Systems for Treating Diabetic Foot Ulcers. | Pharmaceutics | 2023 | 36678887 | PubTator, text mining | PubMed |
| Shared and Related Molecular Targets and Actions of Salicylic Acid in Plants and Humans. | Cells | 2023 | 36672154 | PubTator, text mining | PubMed |
| Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions. | Oncogene | 2023 | 36650218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4922/papers?page=9